Evidence map›Paper›PMID 42428698›Full record

ReviewPublic health reviews2026

Poor adherence to cancer therapy in Ethiopia: systematic review and meta-analysis.

Astewle Andargie Baye, Yirgalem Abere, Demewoz Kefale, Yeshiambaw Eshetie, Mengistu Ewunetu, Lakachew Yismaw Bazezew, Gebrie Kassaw Yirga, Gebrehiwot Berie Mekonnen

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Public health reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Astewle Andargie BayeDepartment of Adult Health Nursing, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Yirgalem AbereDepartment of Adult Health Nursing, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Demewoz KefaleDepartment of Adult Health Nursing, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Yeshiambaw EshetieDepartment of Adult Health Nursing, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Mengistu EwunetuDepartment of Adult Health Nursing, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Lakachew Yismaw BazezewDepartment of Neonatal Nursing, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Gebrie Kassaw YirgaDepartment of Adult Health Nursing, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Gebrehiwot Berie MekonnenDepartment of Pediatrics and Child Health Nursing, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Poor adherence significantly compromises the effectiveness and success of cancer treatment. Understanding the full scope and contributing factors of poor adherence is essential for improving patient care. Therefore, this review aimed to determine the pooled prevalence of poor adherence to cancer therapy in Ethiopia. Methods: The preliminary concepts were registered into PROSPERO. Comprehensive searches of multiple databases were conducted to identify relevant articles. A random-effects model was used to estimate the pooled effect size. Heterogeneity was assessed using the I Results: The analysis includes 15 studies with a total of 7,115 cancer patients. The result indicates that, the overall pooled prevalence of poor adherence to cancer therapy in Ethiopia was 41.45% (95% CI: 33.37-49.52). Comorbidity, treatment side-effects, and residency settings are factors independently associated with poor adherence. Conclusion: Poor adherence to cancer therapy in Ethiopia is significant. Therefore, efforts are needed to increase adherence. Comprehensive and timely management of comorbid conditions and treatment adverse effects can increase adherence to treatment.

Indexed as

adherenceadverse effectscancer therapycomorbidityoncology

Identifiers

PMID42428698
PMCPMC13345979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.